Mannkind

Welcome To The Mannkind HUB On AGORACOM Edit this title from the Fast Facts Section
in response to opc's message

I like this line from the Griffin report...

"Since metformin, which is the first-line therapy, is typically effective for only about 12months, the second study should expand Afrezza’s market to virtually the entire diabetic population."

http://www.griffinsecurities.com/upload/reports/Griffin_MNKD_Research_Note_08Nov11.pdf

Please login to post a reply
brentie98
City
Rank
President
Activity Points
5496
Rating
Your Rating
Date Joined
03/19/2012
Social Links
Private Message
Mannkind
Symbol
MNKD
Exchange
NAZ
Shares
Industry
Technology & Medical
Website
Create a Post